Literature DB >> 29201653

Why are HIV-infected people not started on antiretroviral therapy? A mixed-methods study from Gujarat, India.

S Chawla1, K Shringarpure2, B Modi3, R Sharma4, B B Rewari5, A N Shah6, P B Verma1,3, A R Dongre7, A M V Kumar8,9.   

Abstract

Setting: Five purposively selected antiretroviral therapy (ART) centres in Gujarat, India.
Objectives: To assess the proportion of ART-eligible people living with the human immunodeficiency virus (PLHIV) who were not initiated on ART within 2 months of being recorded as eligible, to identify factors associated with non-initiation and to explore reasons from the provider's perspective. Design: We used a mixed-methods design (triangulation) of 1) a quantitative phase involving record reviews and cohort analysis (Poisson regression) of PLHIV registered during April 2014-March 2015, and 2) a qualitative phase involving one-to-one interviews with 25 providers.
Results: Of 2079 ART-eligible PLHIV, 339 (16%) were not started on ART within 2 months. PLHIV with CD4 counts of <350 cells/μl and patients who were labourers, hospitalised, bedridden or registered with certain ART centres were more likely not to be initiated on ART. Qualitative results were categorised into two broad themes: government health system- and patient-related challenges, which validated and complemented the quantitative findings.
Conclusion: Several patient subgroups at greater risk of ART non-initiation were identified, along with reasons for risk; this has important programme implications for achieving the UNAIDS 90-90-90 goal, and particularly the second 90 component of having 90% of diagnosed PLHIV start ART.

Entities:  

Keywords:  90–90–90; ART-eligible; National AIDS Control Programme; SORT IT; operational research

Year:  2017        PMID: 29201653      PMCID: PMC5676993          DOI: 10.5588/pha.16.0108

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  15 in total

1.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups.

Authors:  Allison Tong; Peter Sainsbury; Jonathan Craig
Journal:  Int J Qual Health Care       Date:  2007-09-14       Impact factor: 2.038

2.  Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.

Authors:  Stephen D Lawn; Landon Myer; Guy Harling; Catherine Orrell; Linda-Gail Bekker; Robin Wood
Journal:  Clin Infect Dis       Date:  2006-08-08       Impact factor: 9.079

3.  Retention in pre-antiretroviral treatment care in a district of Karnataka, India: how well are we doing?

Authors:  D Shankar; A M V Kumar; B Rewari; S Kumar; S Shastri; S Satyanarayana; R Ananthakrishnan; S B Nagaraja; M Devi; N Bhargava; M Das; R Zachariah
Journal:  Public Health Action       Date:  2014-12-21

Review 4.  Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review.

Authors:  Darshini Govindasamy; Nathan Ford; Katharina Kranzer
Journal:  AIDS       Date:  2012-10-23       Impact factor: 4.177

Review 5.  Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.

Authors:  Sydney Rosen; Matthew P Fox
Journal:  PLoS Med       Date:  2011-07-19       Impact factor: 11.069

6.  Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport.

Authors:  Rony Zachariah; Anthony David Harries; Marcel Manzi; Patrick Gomani; Roger Teck; Mit Phillips; Peter Firmenich
Journal:  PLoS One       Date:  2006-12-27       Impact factor: 3.240

7.  Description of the cascade of care and factors associated with attrition before and after initiating antiretroviral therapy of HIV infected children in a cohort study in India.

Authors:  Gerardo Alvarez-Uria
Journal:  PeerJ       Date:  2014-03-13       Impact factor: 2.984

Review 8.  Enhancing the benefits of antiretroviral therapy in Vietnam: towards ending AIDS.

Authors:  Masaya Kato; Nguyen Hoang Long; Bui Duc Duong; Do Thi Nhan; Thi Thuy Van Nguyen; Nguyen Huu Hai; Le Minh Giang; Do Mai Hoa; Nguyen Thanh Van; Amitabh B Suthar; Chris Fontaine; Patrick Nadol; Ying-Ru Lo; Michelle S McConnell
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

9.  The journey to antiretroviral therapy in Karnataka, India: who was lost on the road?

Authors:  Suresh Shastri; Srinath Sathyanarayna; Sharath Burugina Nagaraja; Ajay Mv Kumar; Bharat Rewari; Anthony D Harries; Rony Zachariah
Journal:  J Int AIDS Soc       Date:  2013-08-27       Impact factor: 5.396

10.  Why do Patients in Pre-Anti Retroviral Therapy (ART) Care Default: A Cross-Sectional Study.

Authors:  Jaya Chakravarty; Sangeeta Kansal; Narendra Tiwary; Shyam Sundar
Journal:  Indian J Community Med       Date:  2016 Jul-Sep
View more
  2 in total

1.  Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India.

Authors:  H D Shewade; K S Shringarpure; M Parmar; N Patel; S Kuriya; S Shihora; N Ninama; N Gosai; R Khokhariya; C Popat; H Thanki; B Modi; P Dave; R K Baxi; A M V Kumar
Journal:  Public Health Action       Date:  2018-06-21

2.  Diseases and Disparities: The Impact of COVID-19 Disruptions on Sexual and Reproductive Health Services Among the HIV Community in India.

Authors:  Neha Parikh; Angela Chaudhuri; Syama B Syam; Pratishtha Singh; Prachi Pal; Praneeth Pillala
Journal:  Arch Sex Behav       Date:  2022-01-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.